Providence ALS Center

Portland, Oregon 97213

3 studies enrolling now · 14 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)

Studies at this site

• PREVENT ALL ALS Study — Recruiting now
• ASSESS ALL ALS Study — Recruiting now
• Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY) — Starting soon
• A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) — Completed
• Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Phase 3 Extension Study of Dexpramipexole in ALS — Stopped early
• Phase 3 Study of Dexpramipexole in ALS — Completed
• Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) — Completed
• A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Clinical Trial Nuedexta in Subjects With ALS — Completed
• A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) — Completed